Six1 Promotes Proliferation of Pancreatic Cancer Cells via Upregulation of Cyclin D1 Expression

PLoS ONE

Volumn 8, Issue 3, 2013, Pages

  Li, Zhaoming ^a   Tian, Tian ^a   Lv, Feng ^b   Chang, Yu ^a   Wang, Xinhua ^a   Zhang, Lei ^a   Li, Xin ^a   Li, Ling ^a   Ma, Wang ^a   Wu, Jingjing ^a   Zhang, Mingzhi ^a  

^a THE FIRST AFFILIATED HOSPITAL OF ZHENGZHOU UNIVERSITY   (China)

^b HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLIN D1; MESSENGER RNA; TRANSCRIPTION FACTOR SIX1;

ADULT; ADVANCED CANCER; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CANCER CELL; CANCER GROWTH; CANCER STAGING; CELL CYCLE PROGRESSION; CELL PROLIFERATION; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; HUMAN TISSUE; IN VITRO STUDY; IN VIVO STUDY; MAJOR CLINICAL STUDY; MALE; MOUSE; NONHUMAN; PANCREAS ADENOCARCINOMA; PANCREAS CANCER; PROMOTER REGION; TRANSCRIPTION INITIATION; TUMOR XENOGRAFT; UPREGULATION;

ANALYSIS OF VARIANCE; ANIMALS; BLOTTING, WESTERN; BROMODEOXYURIDINE; CELL LINE, TUMOR; CELL PROLIFERATION; CHROMATIN IMMUNOPRECIPITATION; CYCLIN D1; DNA PRIMERS; GENE EXPRESSION REGULATION, NEOPLASTIC; HOMEODOMAIN PROTEINS; HUMANS; MICE; MICE, INBRED BALB C; MICROARRAY ANALYSIS; PANCREATIC NEOPLASMS; REAL-TIME POLYMERASE CHAIN REACTION; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; TETRAZOLIUM SALTS; THIAZOLES; TUMOR STEM CELL ASSAY;

EID: 84875205667     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0059203     Document Type: Article

References (39)

1. Jemal A, Siegel R, Xu J, Ward E, (2010) Cancer statistics, 2010. CA Cancer J Clin 60: 277-300.
2. Tempero MA, Berlin J, Ducreux M, Haller D, Harper P, et al. (2011) Pancreatic cancer treatment and research: an international expert panel discussion. Ann Oncol 22: 1500-1506.
3. Kumar JP, (2009) The sine oculis homeobox (SIX) family of transcription factors as regulators of development and disease. Cell Mol Life Sci 66: 565-583.
4. Anderson AM, Weasner BM, Weasner BP, Kumar JP, (2012) Dual transcriptional activities of SIX proteins define their roles in normal and ectopic eye development. Development 139: 991-1000.
5. Ford HL, Kabingu EN, Bump EA, Mutter GL, Pardee AB, (1998) Abrogation of the G2 cell cycle checkpoint associated with overexpression of HSIX1: a possible mechanism of breast carcinogenesis. Proc Natl Acad Sci U S A 95: 12608-12613.
6. Zou D, Silvius D, Fritzsch B, Xu PX, (2004) Eya1 and Six1 are essential for early steps of sensory neurogenesis in mammalian cranial placodes. Development 131: 5561-5572.
7. Xu PX, Zheng W, Huang L, Maire P, Laclef C, et al. (2003) Six1 is required for the early organogenesis of mammalian kidney. Development 130: 3085-3094.
8. McCoy EL, Iwanaga R, Jedlicka P, Abbey NS, Chodosh LA, et al. (2009) Six1 expands the mouse mammary epithelial stem/progenitor cell pool and induces mammary tumors that undergo epithelial-mesenchymal transition. J Clin Invest 119: 2663-2677.
9. Laclef C, Souil E, Demignon J, Maire P, (2003) Thymus, kidney and craniofacial abnormalities in Six 1 deficient mice. Mech Dev 120: 669-679.
10. Konishi Y, Ikeda K, Iwakura Y, Kawakami K, (2006) Six1 and Six4 promote survival of sensory neurons during early trigeminal gangliogenesis. Brain Res 1116: 93-102.
11. Reichenberger KJ, Coletta RD, Schulte AP, Varella-Garcia M, Ford HL, (2005) Gene amplification is a mechanism of Six1 overexpression in breast cancer. Cancer Res 65: 2668-2675.
12. Li CM, Guo M, Borczuk A, Powell CA, Wei M, et al. (2002) Gene expression in Wilms' tumor mimics the earliest committed stage in the metanephric mesenchymal-epithelial transition. Am J Pathol 160: 2181-2190.
13. Yu Y, Khan J, Khanna C, Helman L, Meltzer PS, et al. (2004) Expression profiling identifies the cytoskeletal organizer ezrin and the developmental homeoprotein Six-1 as key metastatic regulators. Nat Med 10: 175-181.
14. Ng KT, Man K, Sun CK, Lee TK, Poon RT, et al. (2006) Clinicopathological significance of homeoprotein Six1 in hepatocellular carcinoma. Br J Cancer 95: 1050-1055.
15. Behbakht K, Qamar L, Aldridge CS, Coletta RD, Davidson SA, et al. (2007) Six1 overexpression in ovarian carcinoma causes resistance to TRAIL-mediated apoptosis and is associated with poor survival. Cancer Res 67: 3036-3042.
16. Imam JS, Buddavarapu K, Lee-Chang JS, Ganapathy S, Camosy C, et al. (2010) MicroRNA-185 suppresses tumor growth and progression by targeting the Six1 oncogene in human cancers. Oncogene 29: 4971-4979.
17. Tan J, Zhang C, Qian J, (2011) Expression and significance of Six1 and Ezrin in cervical cancer tissue. Tumour Biol 32: 1241-1247.
18. Zheng XH, Liang PH, Guo JX, Zheng YR, Han J, et al. (2010) Expression and clinical implications of homeobox gene Six1 in cervical cancer cell lines and cervical epithelial tissues. Int J Gynecol Cancer 20: 1587-1592.
19. Coletta RD, Christensen KL, Micalizzi DS, Jedlicka P, Varella-Garcia M, et al. (2008) Six1 overexpression in mammary cells induces genomic instability and is sufficient for malignant transformation. Cancer Res 68: 2204-2213.
20. Coletta RD, Christensen K, Reichenberger KJ, Lamb J, Micomonaco D, et al. (2004) The Six1 homeoprotein stimulates tumorigenesis by reactivation of cyclin A1. Proc Natl Acad Sci U S A 101: 6478-6483.
21. Micalizzi DS, Christensen KL, Jedlicka P, Coletta RD, Barón AE, et al. (2009) The Six1 homeoprotein induces human mammary carcinoma cells to undergo epithelial-mesenchymal transition and metastasis in mice through increasing TGF-beta signaling. J Clin Invest 119: 2678-2690.
22. Wang CA, Jedlicka P, Patrick AN, Micalizzi DS, Lemmer KC, et al. (2012) SIX1 induces lymphangiogenesis and metastasis via upregulation of VEGF-C in mouse models of breast cancer. J Clin Invest 122: 1895-1906.
23. Ng KT, Lee TK, Cheng Q, Wo JY, Sun CK, et al. (2010) Suppression of tumorigenesis and metastasis of hepatocellular carcinoma by shRNA interference targeting on homeoprotein Six1. Int J Cancer 127: 859-872.
24. Schmittgen TD, Livak KJ, (2008) Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc 3: 1101-1108.
25. Rhodes DR, Yu J, Shanker K, Deshpande N, Varambally R, et al. (2004) ONCOMINE: a cancer microarray database and integrated data-mining platform. Neoplasia 6: 1-6.
26. Luo X, Li Z, Li X, Wang G, Liu W, et al. (2011) hSav1 interacts with HAX1 and attenuates its anti-apoptotic effects in MCF-7 breast cancer cells. Int J Mol Med 28: 349-355.
27. Zhang G, Schetter A, He P, Funamizu N, Gaedcke J, et al. (2012) DPEP1 inhibits tumor cell invasiveness, enhances chemosensitivity and predicts clinical outcome in pancreatic ductal adenocarcinoma. PLoS One 7: e31507.
28. Badea L, Herlea V, Dima SO, Dumitrascu T, Popescu I, (2008) Combined gene expression analysis of whole-tissue and microdissected pancreatic ductal adenocarcinoma identifies genes specifically overexpressed in tumor epithelia. Hepatogastroenterology 55: 2016-2027.
29. Donahue TR, Tran LM, Hill R, Li Y, Kovochich A, et al. (2012) Integrative survival-based molecular profiling of human pancreatic cancer. Clin Cancer Res 18: 1352-1363.
30. Luo X, Li Z, Yan Q, Li X, Tao D, et al. (2009) The human WW45 protein enhances MST1-mediated apoptosis in vivo. Int J Mol Med 23: 357-362.
31. Laurance ME, Starr DB, Michelotti EF, Cheung E, Gonzalez C, et al. (2001) Specific down-regulation of an engineered human cyclin D1 promoter by a novel DNA-binding ligand in intact cells. Nucleic Acids Res 29: 652-661.
32. Ishikawa M, Yoshida K, Yamashita Y, Ota J, Takada S, et al. (2005) Experimental trial for diagnosis of pancreatic ductal carcinoma based on gene expression profiles of pancreatic ductal cells. Cancer Sci 96: 387-393.
33. Buchholz M, Braun M, Heidenblut A, Kestler HA, Klöppel G, et al. (2005) Transcriptome analysis of microdissected pancreatic intraepithelial neoplastic lesions. Oncogene 24: 6626-6636.
34. Pei H, Li L, Fridley BL, Jenkins GD, Kalari KR, et al. (2009) FKBP51 affects cancer cell response to chemotherapy by negatively regulating Akt. Cancer Cell 16: 259-266.
35. Yu Y, Davicioni E, Triche TJ, Merlino G, (2006) The homeoprotein six1 transcriptionally activates multiple protumorigenic genes but requires ezrin to promote metastasis. Cancer Res 66: 1982-1989.
36. Liu Y, Nandi S, Martel A, Antoun A, Ioshikhes I, et al. (2012) Discovery, optimization and validation of an optimal DNA-binding sequence for the Six1 homeodomain transcription factor. Nucleic Acids Res.
37. Abate-Shen C, (2002) Deregulated homeobox gene expression in cancer: cause or consequence? Nat Rev Cancer 2: 777-785.
38. Malumbres M, Barbacid M, (2009) Cell cycle, CDKs and cancer: a changing paradigm. Nat Rev Cancer 9: 153-166.
39. Musgrove EA, Caldon CE, Barraclough J, Stone A, Sutherland RL, (2011) Cyclin D as a therapeutic target in cancer. Nat Rev Cancer 11: 558-572.